Mouse models to study the role of telomeres in cancer, aging and DNA repair

European Journal of Cancer

Volumn 38, Issue 17, 2002, Pages 2222-2228

  Blasco, María A ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Aging; Cancer; DNA repair; Mouse models; Telomerase; Telomeres

Indexed keywords

BINDING PROTEIN; M PROTEIN; TANKYRASE; TELOMERASE; TELOMERASE INHIBITOR; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

AGING; CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL ACTIVITY; CELL AGING; CHEMICAL CARCINOGENESIS; CHROMOSOME; CHROMOSOME BREAKAGE; CHROMOSOME STRUCTURE; DISEASE MODEL; DNA REPAIR; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; MITOSIS INHIBITION; MOUSE STRAIN; NONHUMAN; PREMATURE AGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; SYNTHESIS; TELOMERE;

EID: 0036849595     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00450-1     Document Type: Article

References (66)

1. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
2. Chan S.W.-L., Blackburn E.H. New ways not to make ends meet. telomerase, DNA damage proteins and heterochromatin Oncogene. 21:2001;553-563.
3. De Lange T. Protection of mammalian telomeres. Oncogene. 21:2002;532-540.
4. Griffith J.D., Comeau L., Rosenfield S.et al. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
5. Goytisolo F.A., Blasco M.A. Many ways to telomere dysfunction. in vivo studies using mouse models Oncogene. 21:2002;584-591.
6. Blasco M.A., Lee H.W., Hande M.P.et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
7. Espejelet al. Mammalian Ku86 mediates chromosomal fusions apoptosis caused by critically short telomeres. EMBO J. 21:2002;2207-2219.
8. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat Genet. 17:1997;236-239.
9. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet. 17:1997;231-235.
10. Chong L., van Steensel B., Broccoli D.et al. A human telomeric protein. Science. 270:1995;1663-1667.
11. Smogorzewska A., van Steensel B., Bianchi A.et al. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol. 20:2000;1659-1668.
12. Kim S.H., Kaminker P., Campisi J. TIN2, a new regulator of telomere length in human cells. Nat Genet. 23:1999;405-412.
13. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science. 282:1998;1484-1487.
14. Kaminker P.G., Kim S.H., Taylor R.D.et al. TANK2, a new TRF1-associated PARP, causes rapid induction of cell death upon overexpression. J. Biol. Chem. 276:2001;35891. (3589).
15. Smith S., de Lange T. Tankyrase promotes telomere elongation in human cells. Curr Biol. 10:2000;1299-1302.
16. Bürkle A., Schreiber V., Dantzer F.et al. Biological significance of poly(ADP-ribosyl)ation reactions. molecular and genetic approaches de Murcia G., Shall S. From DNA Damage and Stress Signaling to Cell Death. Poly ADP-ribosylation Reactions. 2000;80-124 Oxford University Press, Oxford.
17. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413.
18. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
19. Li B., Oestreich S., de Lange T. Identification of human Rap1. implications for telomere evolution Cell. 101:2000;471-483.
20. Zhu X.D., Kuster B., Mann M., Petrini J.H., Lange T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet. 25:2000;347-352.
21. Smith G.C., Jackson S.P. The DNA-dependent protein kinase. Genes Dev. 13:1999;916-934.
22. Bianchi A., de Lange T. Ku binds telomeric DNA in vitro. J Biol Chem. 274:1999;21223-21227.
23. Hsu H.L., Gilley D., Blackburn E.H., Chen D.J. Ku is associated with the telomere in mammals. Proc Natl Acad Sci USA. 96:1999;12454-12458.
24. Hsu H.L., Gilley D., Galande S.A.et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev. 14:2000;2807-2812.
25. Song K., Jung D., Jung Y., Lee S.G., Lee I. Interaction of human Ku70 with TRF2. FEBS Lett. 481:2000;81-85.
26. Bailey S.M., Meyne J., Chen D.J.et al. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci USA. 96:1999;14899-14904.
27. Samper E., Goytisolo F.A., Slijepcevic P., van Buul P.P., Blasco M.A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO rep. 1:2000;244-252.
28. Goytisolo F.A., Samper E., Edmonson S., Taccioli G.E., Blasco M.A. The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol Cell Biol. 21:2001;3642-3651.
29. Bailey S.M., Conforth M.N., Kurimasa A., Chen D.J., Goodwin E.H. Strand-specific postreplicative processing of mammalian telomeres. Science. 293:2001;2462-2465.
30. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 292:2001;1171-1175.
31. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
32. Collins K., Mitchell J.R. Telomerase in the human organism. Oncogene. 21:2002;564-579.
33. Collins K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12:2000;378-383.
34. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature. 392:1998;569-574.
35. Herrera E., Samper E., Martin-Caballero J., Flores J.M., Lee H.W., Blasco M.A. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. Embo J. 18:1999;2950-2960.
36. -/- mice with short telomeres. EMBO Reports. 2:2001;1-8.
37. Hemann M.T., Strong M.A., Hao L.Y., Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell. 107:2001;67-77.
38. Bodnar A.G.et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
39. Hiyama E., Hiyama K. Clinical utility of telomerase in cancer. Oncogene. 21:2002;643-649.
40. Zumstein L.A., Lundblad V. Telomeres. has cancer's Achilles' heel been exposed? Nature Med. 5:1999;1129-1130.
41. Mattson M.P., Fu W., Zhang P. Emerging roles for telomerase in regulating cell differentiation and survival. a neuroscientist's perspective Mech. Aging and Dev. 122:2001;659-671.
42. Blasco MA. Telomerase beyond telomeres. Nature Reviews Cancer, in press.
43. Bryan T.M., Englezou A., Dalla-Pozza L., Dunham M.A., Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 3:1997;1271-1274.
44. Dunham M.A., Neumann A.A., Fasching C.L., Reddel R.R. Telomere maintenance by recombination in human cells. Nat Genet. 26:2000;447-450.
45. Blasco M.A., Funk W.D., Villeponteau B., Greider C.W. Functional characterization and developmental regulation of mouse telomerase RNA. Science. 269:1995;1267-1270.
46. Herrera E., Samper E., Blasco M.A. Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube. Embo J. 18:1999;1172-1181.
47. Rudolph K.L., Chang S., Lee H.W.et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 96:1999;701-712.
48. Herrera E., Martinez A.C., Blasco M.A. Impaired germinal center reaction in mice with short telomeres. Embo J. 19:2000;472-481.
49. Franco S., Segura I., Riese H., Blasco M.A. Telomere length is a key molecular determinant of angiogenic potential in vivo. implications for cancer and aging Cancer Research. 62:2002;552-559.
50. Samper E., Fernández P., Martín-Rivera L., Bernad A., Blasco M.A., Aracil M. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood. 99:2002;2767-2775.
51. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer. 33:1997;787-791.
52. Gonzalez-Suarez E., Samper E., Flores J.M., Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet. 26:2000;114-117.
53. Chin L., Artandi S.E., Shen Q.et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:1999;527-538.
54. Artandi S.E., Chang S., Lee S.L.et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 406:2000;641-645.
55. Rudolph K.L., Millard M., Bosenberg M.W., DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet. 28:2001;155-159.
56. Greenberg R.A., Chin L., Femino A.et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell. 97:1999;515-525.
57. Goytisolo F.A., Samper E., Martin-Caballero J.et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med. 192:2000;1625-1636.
58. Wong K.K., Chang S., Weiler S.R.et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet. 26:2000;85-88.
59. Blasco M.A., Rizen M., Greider C.W., Hanahan D. Differential regulation of telomerase activity and its RNA component during multistage tumorigenesis. Nat Genet. 12:1996;200-204.
60. Broccoli D., Godley L.A., Donehower L.A., Varmus H.E., de Lange T. Telomerase activation in mouse mammary tumors. lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation Mol Cell Biol. 16:1996;3765-3772.
61. Gonzalez-Suarez E., Samper E., Ramirez A.et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. Embo J. 20:2001;2619-2630.
62. González-Suárez E, Flores JM, Blasco MA. Coorperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol Cell Biol, in press.
63. Artandiet al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA. 99:2002;8191-8196.
64. Nussenzweig A., Chen C., da Costa Soares V.et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
65. Vogel H., Lim D.S., Karsenty G., Finegold M., Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci USA. 96:1999;10770-10775.
66. Difilippantonio M.J., Zhu J., Chen H.T.et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature. 404:2000;510-514.